[Event Report] The First Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (September 14, 2020)
date : 9/25/2020
Tags: AMR
Nikkei Inc. and AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) jointly held the First Meeting of Working Group (WG) 3 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC).
The WGs were established under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) in order to discuss the state of the antimicrobial market.
At this First meeting of WG3, participants discussed messaging on AMR, the priority issues that need to be dealt with in order to increase understanding of AMR, and the causal relationship between those issues.
On the basis of the WG discussions, participants agreed to join the third sub-committee on AMR and continue to work hard toward the eventual formulation of a concrete proposal on ways to incentivize antimicrobial R&D in the future and to promote educational support activities related to AMR for healthcare professionals and the general public.
In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Thursday, September 14, 2020
Organizer: AMR Alliance Japan (Secretariat: HGPI), Nikkei Inc.
■Discussion
WG3 Members (alphabetical order by last name):
Kyoko Ama (Board Member, Japan Patient Support Research Organization)
Yoshiaki Gu (Chief, Information and Education Division, AMR Clinical Reference Center, National Center for Global Health and Medicine)
Midori Hirai (Auditor, The Pharmaceutical Society of Japan / Director, Japanese Red Cross Hyogo Blood Center)
Hajime Matsumoto (Public and Industry Policy, Health Policy, MSD K. K.)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Moderator:
Yuiko Kondo (AMR Alliance Japan Secretariat / Senior Associate, HGPI)
Secretariat (alphabetical order by last name):
Yui Kohno (AMR Alliance Japan Secretariat / Associate, HGPI)
Matt McEnany (AMR Alliance Japan Secretariat / Senior Manager, HGPI)
Tomohito Shibata (AMR Alliance Japan Secretariat / Senior Associate, HGPI)
Mio Wakasa (Nikkei FT Communicable Diseases Conference, Nikkei Inc.)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] “Balancing Sustainability and Innovation in the Healthcare System” (December 26, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
-
2026-01-22
[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
-
2026-01-26
[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)



